6 month semaglutide Medscape | (Wegovy) is associated with a 41% reduction in the risk for major adverse cardiovascular events (MACEs) within months of Semaglutide Results at 6 Months:

You can usually manage it with electrolyte hydration, low-fat meals, and dose-aware meal timing without stopping treatment

Tirzepatide for metabolic DysfunctionAssociated steatohepatitis with liver fibrosis

This dual mechanismrapid weight loss combined with potential direct effects on gallbladder functionmay explain the observed association between GLP-1 therapy and gallstone risk

For many people, a meal replacement shake can be used as part of their nutrition while taking a GLP-1 medication, but it's always worth checking with your own doctor or healthcare team

Ethical triage may reduce short-term surgical conversion, but it builds trust, referral quality and long-term practice reputation